...
首页> 外文期刊>Journal of Clinical and Diagnostic Research >Tryptophan Hydroxylase 2 Gene Polymorphism in Anxiety and Depressive Disorder in Kashmiri Population
【24h】

Tryptophan Hydroxylase 2 Gene Polymorphism in Anxiety and Depressive Disorder in Kashmiri Population

机译:克什米尔人焦虑和抑郁症的色氨酸羟化酶2基因多态性

获取原文
           

摘要

Background: The gene of tryptophan hydroxylase is widely recognized as a major candidate gene in many psychiatric disorders. However, no study has been done which investigates tryptophan hydroxylase 2 gene polymorphism in anxiety and depressive disorders in Kashmiri population (India). Objectives: To study tryptophan hydroxylase 2 (TPH2) C 11993 A gene polymorphism in anxiety and depressive disorders.Method: Sixty patients of depression disorder, 60 patients of anxiety disorder and 40 unrelated healthy volunteers (control) were studied in a case control design. Polymorphism was determined using polymerase chain reaction (PCR) and agarose gel electrophoresis after digestion with HAP II enzyme. Genotypes and allele frequencies were compared using Chi-square tests, Fischer?s exact test, odds ratio, 95% confidence interval (C.I) and p-value of <0.05 was considered to be statistical significant.Results: The mean age ± SD of anxiety, depression and control group was 32.73±10.99, 32.20±10 and 29.75±10.12 respectively and the difference was found to be statistically non significant (p=0.349).The mean HAM-A (Hamilton rating scale for anxiety) score and HAM-D (Hamilton rating scale for depression) score was high in both groups (anxiety and depression) and found to be statistically significant (p=0.001).Depression group had AA genotype (55.2%) than control (37.5%) and was found to be statistically non significant (p=0.890).Comparison of allelic frequency revealed no association of A allele in anxiety group (76.67%) compared with control (75.5%) and was found to be statistically non significant (p= 0.866), OR 1.09 (0.56-2.11).Conclusion: TPH2C 11993 A gene was not found to be associated with major depressive disorder (MDD) and anxiety disorder in Kashmiri population.
机译:背景:色氨酸羟化酶基因被广泛认为是许多精神疾病的主要候选基因。但是,尚未进行研究色氨酸羟化酶2基因多态性在克什米尔人(印度)的焦虑和抑郁症中的研究。目的:研究色氨酸羟化酶2(TPH2)C 11993 A基因多态性与焦虑症和抑郁症的关系。方法:采用病例对照设计,研究了60例抑郁症患者,60例焦虑症患者和40名无关的健康志愿者(对照组)。用HAP II酶消化后,使用聚合酶链反应(PCR)和琼脂糖凝胶电泳确定多态性。使用卡方检验,Fischer精确检验,比值比,95%置信区间(CI)和p值<0.05来比较基因型和等位基因频率具有统计学意义。结果:平均年龄±焦虑,抑郁和对照组的SD分别为32.73±10.99、32.20±10和29.75±10.12,差异无统计学意义(p = 0.349).HAM-A(汉密尔顿焦虑量表)评分的平均值两组(焦虑和抑郁)和HAM-D(汉密尔顿抑郁量表)得分均较高,且具有统计学意义(p = 0.001)。抑郁组的AA基因型(55.2%)高于对照组(37.5%)。差异无统计学意义(p = 0.890)。等位基因频率的比较显示,与对照组(75.5%)相比,焦虑组(76.67%)与A等位基因没有关联,并且发现统计学上无统计学意义(p = 0.866),或1.09(0.56-2.11)。结论:未发现TPH2C 11993 A基因与克什米尔居民的严重抑郁症(MDD)和焦虑症相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号